Skip to content
Screener

Operating margin at other companies

Supernus Pharmaceuticals logo
Supernus PharmaceuticalsSUPN
-7.8%-18.9pp
Xenon Pharmaceuticals logo
Xenon PharmaceuticalsXENE
-4,974.3%
Praxis Precision Medicines, Inc. logo
Praxis Precision Medicines, Inc.PRAX
-3,927.5%-1,497pp
Septerna, Inc. logo
Septerna, Inc.SEPN
-77.1%-38.4pp
Neuropace, Inc. logo
Neuropace, Inc.NPCE
-16.8%-3.5pp
CalAmp logo
CalAmpCAMP
-1,335.2%-512pp

Other financials

Income statement

See full
Revenue-
Operating income-$60.8M-106%
Net income-$56.6M-112%
EPS (diluted)-$1.19-58.7%

Balance sheet

See full
Cash & equivalents$63.6M+15.5%
Total debt$10.1M-14.8%
Total equity$422.9M+60.5%
Total assets$459.0M+60.8%

Cash flow

See full
Operating cash flow-$41.5M-65.4%
CapEx$78.0K+255%
Free cash flow-$41.5M-65.5%

Valuation

See full
Market cap$2.22B+317%
Enterprise value$2.17B+343%
P/S111.2×

Profitability

See full
Net margin-685.8%
FCF margin-485.7%

Returns & leverage

See full
Return on equity-40%+22.3pp
Debt / equity0.0×
Current ratio15.7×-7.0×